Merck is expanding its membrane and filtration manufacturing capabilities in Ireland. The company will invest approximately €440 million.

Merck Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland

– Company to invest in two major Life Science projects over five years
– Significantly increases membrane manufacturing capacities and enables construction of new filtration manufacturing facility
– Supports Merck’s strategy to invest in products and technologies across its portfolio that are key to…

18.02.2022
‌
Company

Merck Announces Organizational Transformation of Life Science Business Sector to Strengthen CDMO Offering and Accelerate Future Growth

– New operating model to accelerate profitable growth strategy
– Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
– Science and Lab Solutions business unit to combine Research Solutions and Applied Solutions
– Christos Ross, Head of Integrated…

16.10.2021
‌
Company

Merck announced the opening of its second Carlsbad, California-based facility, significantly expanding its global CDMO footprint.

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

– Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors
– Investment serves customers in addressing larger patient populations with new curative treatments
– Enables suspension production of viral vectors up to 1,000-lit…

A look at the NEWSLETTER

Better informed: With YEARBOOK, NEWSLETTER, NEWSFLASH and EXPERT DIRECTORY

Stay up to date and subscribe to our monthly eMail-NEWSLETTER and our NEWSFLASH. Get additional information about what is happening in the world of cleanrooms with our printed YEARBOOK. And find out who the cleanroom EXPERTS are with our directory.